Background: Bao-Xin-Tang (BXT) is a traditional Chinese medicinal formula used for the treatment of coronary heart disease and
Introduction
In the United States (US), over 800,000 people suffer from acute myocardial infarction (AMI) every year, with 27% mortality (Boateng and Sanborn, 2013) . Although the incidence of AMI has decreased in the US, according to the American Heart Association, heart disease remains the leading cause of death worldwide (O'Gara et al., 2013). Acute intravascular coronary thrombus formation within a visceral pericardium coronary artery is the underlying pathology of AMI (Kloner, 2006) . Pathological and clinical studies have suggested that arterial inflammation is the most common cellular and molecular mechanism, after the rupture of an atherosclerotic plaque (O'Gara et al., 2013; Kloner, 2006) . Oxidative stress also plays a crucial role in the process of AMI (Przybyt et al., 2013) . The main concern is to find an effective way to minimize myocardial damage and rapidly rescue the affected myocardium after AMI. Although primary percutaneous coronary intervention (PCI) and thrombolytic therapy are important revascularization treatments (Yip et al., 2002) , aborted reperfusion, such as during miscarry after the infarct artery reopens through thrombolytic therapy, rats (180-220 g body weight). Rats were housed in polyethylene cages, three per cage, and food and water were provided ad libitum.
Rats were housed under standard conditions at 22°C, with relative humidity at 40%-60% and a 12 h light/dark cycle. Before any experiment, rats were allowed a 1-week acclimatization period.
All rats were randomly divided into four groups as follows: i) sham operation group (sham MI; rats in this group had sutures passing around the left main coronary artery without ligations); ii) vehicle control group [MI + vehicle; rats were treated with vehicle (0.9% NaCl, 20 mL/kg)]; iii) lower dosage BXT group (MI + BXT; at 30 min before myocardial ischemia, rats were orally administered BXT extract at 12 g/kg); and, iv) higher dose BXT group (MI + BXT; at 30 min before myocardial ischemia, rats were orally administered BXT extract at 36 g/kg). The drug dose given to the rats was based on the following principles. The lower dose of BXT given to rat model was 12 g/kg, which is approximately 6.7 times that used by humans. This dose has been previously reported (PINKEL et al., 2011) . BXT in the high dose group was 36 g/kg, which is 3 times of lower dose, without obvious side effects.
Acute myocardial infarction rat model preparation
We performed the surgical operations as previously described (Qin et al., 2009 ). The recommended dose of pentobarbital for intraperitoneal injection was 36 mg/kg. Intubation was through a tracheotomy, and ventilation used a DHX-500B small animal ventilator [RR = 60 beats per minute (bpm), V T = 2-3 mL/100 g, I:E = 1:2]. Electrodes were inserted subcutaneously to record the electrocardiogram (ECG) of the rat throughout the entire experiment (RM6240BD; Extension Equipment Co., Shanghai, China). The chest was opened by means of a left thoracotomy, and the heart was exposed through the use of a retractor and forceps. A 3-0 suture was used to ligate the left anterior descending coronary artery. Typical arrhythmia from AMI was successfully established using this rat model. The heart was immediately returned to its anatomical location, and a sternum incision was done with final skin suturing.
After 3 h of ischemia, the heart was quickly removed, and the myocardial tissue was processed as follows.
Measurement of infarct size
The infarct size was measured as previously described (Yu et al., 2013) . The heart was quickly removed at 3 h after occlusion of the left anterior descending coronary artery (LAD). Samples were frozen at −20°C, then the left ventricles were sectioned into 2-mm thick sections from the apex to the coronary sulcus. Infarct size was determined using 1% triphenyl tetrazolium chloride (TTC) staining (Nanjing Jiancheng Bioengineering Institute, Nanjing, Jiangsu, China) at 37°C for 30 min. The normal cardiac tissue was bright red while the ischemic myocardium appeared pale. Image-Pro Plus 6.0 software (Media Cybernetics, Inc., Rockville, MD, USA) was to measure the size of the infarct area.
Inflammatory factor assays
An enzyme-linked immunosorbent assay (ELISA) was used to measure the serum levels of C-reactive protein (CRP), interleukin-6 (IL-6), and interleukin-10 (IL-10). Each kit was provided by Weier Research (Hunan Province, China). After 3 h of acute myocardial ischemia, a serum separator tube was used for 30 min on all clotted blood samples. Whole blood was separated from serum at 1,000 rpm, according to the manufacturer's instructions, and 100 μL of standard blank or serum sample were incubated for 2 h at 37°C, with detection reagent A (100 μL) added to each well, then incubated for 1 h at 37°C. Samples were washed with buffer, then 100 μL of detection reagent B was added to each well, and further incubated for 1 h at 37°C, with rinsing, once. After the addition of 90 μL of substrate solution, followed by incubation for 20 min, 50 μL of stop solution was added at room temperature. 
Antioxidant assays
Blood samples were collected from the abdominal aorta to measure the activities of superoxide dismutase (SOD) and myeloperoxidase (MPO) activities. Whole blood was separated for 10 min at 3,000 rpm, and blood samples were then used to measure levels of SOD and MPO using diagnostic kits, following the manufacturer's instructions (Huamei, Wuhan, China).
Statistical analysis
All data were expressed as mean ± standard deviation (SD) for 6 rats in each group. Experimental results were analyzed using one-way ANOVA followed by least significant difference (LSD) tests for individual comparisons between group means, while the Tamhane t-test method was used when the variance was arrhythmic. All data were analyzed using Social Science (SPSS) 17.0 software (Armonk, New York, USA). A value of P < 0.05 was considered statistically significant.
Results

Effects of BXT on myocardial infarct size
As shown in Figure. 1, we measured the myocardial infarct size to determine the protective effects of BXT on the acute myocardial infarction range in experimental rats. Interestingly, in the vehicle-treated group the myocardial infarct was 53.37 ± 2.30%.
After oral treatment with BXT at doses of 12 and 36 g/kg, the myocardial infarct area was significantly smaller compared with the vehicle-treated group, respectively (MI+12 g/kg, 31.96 ± 1.70%; MI+36 g/kg, 23.24 ± 1.33%; P < 0.01). We determined the serum levels of CRP, IL-6, and IL-10 to confirm if BXT reduced the inflammatory response. As shown in Figure. 2A-C, the serum levels of CRP and IL-6 in the BXT-treated group were reduced compared to the vehicle-treated group (P < 0.05). The serum levels of IL-10 in the BXT (36 g/kg)-treated group were significantly increased compared to the vehicle-treated group (P < 0.05). However, there was no significant difference between the 12 g/kg BXT dose and the vehicle-treated groups (P > 0.05).
Figure 2:
Effects of BXT on the concentrations of circulating inflammatory markers, C-reactive protein (CRP), serum interleukin-6 (IL-6), and interleukin-10 (IL-10) in the sham MI group (n = 6), the MI + vehicle group (orally administered vehicle, n = 6), the MI + BXT (orally administered BXT extract at 12 g/kg; n = 6), and the MI + BXT group (orally administered BXT extract at 36 g/kg; n = 6).
(A) Serum CRP levels; (B) serum IL-6 levels; (C) serum IL-10 levels. *P < 0.05 and **P < 0.01 vs. the vehicle-treated group. MI, myocardial infarction; BXT, Bao-Xin-Tang.
Antioxidant assays
In the BXT-treated groups, the serum SOD levels were significantly increased (P < 0.01 or 0.05; Figure. 3A ), while the levels of serum MPO were decreased compared to the vehicle-treated groups (P < 0.01; Figure. MI + vehicle group (orally administered vehicle, n = 6), MI + BXT (orally administered BXT extract at 12 g/kg; n = 6), and MI + BXT (orally administered BXT extract at 36 g/kg; n = 6). Serum levels of SOD and MPO were determined by ELISA. *P < 0.05 and **P < 0.01 vs. the vehicle-treated group.
Discussion and Conclusion
The results of this study confirm that: (Boateng and (Ferreira, 2010) .
In AMI, the inflammatory response plays a critical role (Frangogiannis et al., 2002) , through the secretion of inflammatory cytokines, and inflammatory cells that aggregate and infiltrate during the inflammatory process (Speyer and Ward, 2011) .
Atherosclerosis is a serious inflammatory disease of the blood vessels, and inflammatory processes participate during the entire period of atherosclerosis (Li, 2005) , causing the delay of coronary reflow, coronary microvascular endothelial dysfunction, and vascular restenosis (Li, There are numerous studies describing the effects of myocardial infarction. Data show that heart failure follows myocardial infarction, by altering the oxidative condition and decreasing myocardial antioxidant ability (Hill and Singal 1996) .
Oxidative stress is often caused by an imbalance between reactive oxygen species (ROS) and the defense system against antioxidants and hydrogen radicals, are detected in the myocardium of failing hearts of rats (Rajadurai and Stanely, 2006) . Lipid peroxidation is a biomarker of oxidative stress, and it participates in the injury mechanism of cells. Increased lipid peroxidation, derived from oxidative stress, alters the cellular balance between pro-oxidants and antioxidants (Kumari and Menon, 1987 ) . Superoxide can remove lipid peroxides by regulating the balance between oxidation and anti-oxidation reactions, thus preventing the formation of atherosclerosis (Halliwell, 1994; Kiruthiga et al., 2007) . Myeloperoxidase (MPO) is a heme protein, which is secreted by activated human leukocytes.
It promotes lipid peroxidation in vitro through the production of reactive intermediates, and MPO is a major source of oxidation during stress-induced inflammation (Zhang et al., 2002) . The activities of SOD and MPO show a close relationship with cardiac muscle injury. Our results suggest that SOD activity in the treatment group was increased, and MPO levels were significantly decreased when compared with the vehicle-treated group. Because BXT increases the oxygen free radical scavenging system in cells, reduces free radical production, and decreases lipid peroxidation product formation, the damage from myocardial oxygen free radicals and myocardial ischemia injury is reduced. In summary, the BXT cardioprotective mechanism is still not fully understand because BXT is a complex mixture of herbs, and the role of each individual component has not been determined. Consequently, additional studies are necessary to identify and characterize the actions of the individual components of BXT. The current study demonstrates 
